<DOC>
	<DOCNO>NCT01848184</DOCNO>
	<brief_summary>The objective study assess recurrence rate follow use PARIETEX™ Composite Ventral Patch primary ventral hernia repair open approach intra‐peritoneal positioning .</brief_summary>
	<brief_title>A Prospective Study Patients Undergoing Primary Ventral Hernia Repair Using Parietex™ Composite Ventral Patch</brief_title>
	<detailed_description>Prospective , multicenter , multinational non‐comparative study . Primary Endpoint : Primary hernia recurrence* rate 24 month follow‐up . The evaluation hernia recurrence perform physical examination ultrasonography . Secondary Endpoints : Primary hernia recurrence* rate 1 , 6 12 month follow‐up . The evaluation hernia recurrence perform physical examination confirm ultrasonography . ( *Recurrence define clinically manifest bulge protrusion exacerbate Valsalva maneuver . ) Safety Parameters : Deep superficial infection ( A Surgical Site Infection ( SSI ) define study accord Centers Disease Control Prevention ( CDC ) criteria diagnosis SSI ) . Pain / Chronic pain Other post‐operative complication ( complication relate visceral adhesion , Ileus , seroma , hematoma ... ) Analgesics consumption Risk factor ( severity treatment ) Efficacy Parameters : Recurrence primary ventral hernia Operative time Time mesh positioning Length Hospital Stay Ease use ( Mesh handle manipulability , comfort use … ) Return daily activities/ work Patient satisfaction Patient comfort ( Carolina's™ Comfort scale ( CCS ) - QoL questionnaire ) Visit Schedule : Baseline visit ( Preoperative ) &amp; Operative/Discharge visit Post-Op : Phone call Day 10 1 month 6 month 12 month 24 month Duration : 12 month recruitment 24 month follow‐up Up 12 site Europe United States include study</detailed_description>
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Hernia , Ventral</mesh_term>
	<criteria>All patient ( adult ≥ 18 year ) participate centre undergo primary ventral hernia repair device open approach Signed informed consent form patient legally authorize representative Intraoperative inclusion criterion : Size defect : ≤ 4 cm Emergency procedure Current participation trial History previous hernia location . Pregnant woman : Women know suspect pregnant , plan become pregnant study follow‐up period Patient &lt; 18 year BMI &gt; 35 ASA score ≥ 4 The investigator determine patient able comply require follow‐up visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>PARIETEX Composite Ventral Patch</keyword>
	<keyword>PCO VP OR PCOVP</keyword>
	<keyword>Primary ventral hernia repair</keyword>
	<keyword>Panacea</keyword>
</DOC>